JP2006265231A5 - - Google Patents

Download PDF

Info

Publication number
JP2006265231A5
JP2006265231A5 JP2006035113A JP2006035113A JP2006265231A5 JP 2006265231 A5 JP2006265231 A5 JP 2006265231A5 JP 2006035113 A JP2006035113 A JP 2006035113A JP 2006035113 A JP2006035113 A JP 2006035113A JP 2006265231 A5 JP2006265231 A5 JP 2006265231A5
Authority
JP
Japan
Prior art keywords
oxypropylcellulose
honey
drinks
fragrance
injections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006035113A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006265231A (ja
JP5039305B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2006035113A priority Critical patent/JP5039305B2/ja
Priority claimed from JP2006035113A external-priority patent/JP5039305B2/ja
Publication of JP2006265231A publication Critical patent/JP2006265231A/ja
Publication of JP2006265231A5 publication Critical patent/JP2006265231A5/ja
Application granted granted Critical
Publication of JP5039305B2 publication Critical patent/JP5039305B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006035113A 2005-02-28 2006-02-13 予防的抗ストレス剤 Expired - Fee Related JP5039305B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006035113A JP5039305B2 (ja) 2005-02-28 2006-02-13 予防的抗ストレス剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005054532 2005-02-28
JP2005054532 2005-02-28
JP2006035113A JP5039305B2 (ja) 2005-02-28 2006-02-13 予防的抗ストレス剤

Publications (3)

Publication Number Publication Date
JP2006265231A JP2006265231A (ja) 2006-10-05
JP2006265231A5 true JP2006265231A5 (cg-RX-API-DMAC7.html) 2009-02-19
JP5039305B2 JP5039305B2 (ja) 2012-10-03

Family

ID=37201559

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006035113A Expired - Fee Related JP5039305B2 (ja) 2005-02-28 2006-02-13 予防的抗ストレス剤

Country Status (1)

Country Link
JP (1) JP5039305B2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11160840B2 (en) * 2016-12-30 2021-11-02 Industry-Academic Cooperation Foundation, Yonsei University Composition for improvement of muscle function containing 3,5-dicaffeoylquinic acid or chrysanthemum extract

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3548102B2 (ja) * 2000-08-07 2004-07-28 花王株式会社 高血圧症予防・治療剤
JP2002154977A (ja) * 2000-09-05 2002-05-28 Kao Corp 飲食用組成物
JP4077149B2 (ja) * 2000-11-02 2008-04-16 花王株式会社 自律神経機能向上剤
JP2003212782A (ja) * 2002-01-23 2003-07-30 Kao Corp 便性改善剤
JP2003261444A (ja) * 2002-03-06 2003-09-16 Kao Corp 血管内皮機能改善剤

Similar Documents

Publication Publication Date Title
US8580855B2 (en) Acetaminophen / ibuprofen combinations and method for their use
US9339511B2 (en) Pharmaceutical formulation containing choline alfoscerate
IL259851A (en) Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders
NO20082744L (no) Oral farmasoytisk doseform omfattende som aktive ingredienser en proton pumpeinhibitor sammen med acetylsalicylsyre
TW200803826A (en) Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol
WO2008011169A3 (en) Controlled release formulations and associated methods
WO2008038705A1 (en) Glycation inhibitor
WO2007113008A3 (en) Opaque container comprising food or pharmaceutical products or herbal(s)
WO2010127205A3 (en) Fixed dose drug combination formulations
JP2011506587A5 (cg-RX-API-DMAC7.html)
KR102193599B1 (ko) 발포성 조성물 및 이의 제조방법
JP2007523135A5 (cg-RX-API-DMAC7.html)
WO2008116601A3 (en) Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
US20080014257A1 (en) Oral dosage forms
WO2010098627A2 (ko) 약제학적 제제
JP2008531029A5 (cg-RX-API-DMAC7.html)
WO2006103672A3 (en) Spherically shaped substances
JP6907470B2 (ja) 固形製剤
JP2007290977A5 (cg-RX-API-DMAC7.html)
WO2004004705A3 (en) Pharmaceutical formulations for preparing drink products
WO2008147169A3 (es) Microemolsion conteniendo pirfenidona
JP2006160721A5 (cg-RX-API-DMAC7.html)
WO2004093867A3 (en) Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
WO2006125496A3 (en) Pharmaceutical formulations comprising active pharmaceutical principles absorbed on titanium dioxide nanoparticles
RU2007132449A (ru) Профилактическое антистрессовое средство